Merck KGaA (MKGAF) Filings

SC TO-T/A

Third party tender offer statement (amended)

12 Apr 19

SC TO-T/A

Third party tender offer statement (amended)

8 Apr 19

SC TO-T/A

Third party tender offer statement (amended)

1 Apr 19

SC TO-T

Third party tender offer statement

26 Mar 19

DFAN14A

Additional proxy materials by non-management

4 Jun 19

DFAN14A

Additional proxy materials by non-management

15 May 19

DFAN14A

Additional proxy materials by non-management

6 May 19

DFAN14A

Additional proxy materials by non-management

1 May 19

DFAN14A

Additional proxy materials by non-management

15 Apr 19

DFAN14A

Additional proxy materials by non-management

12 Apr 19

DFAN14A

Additional proxy materials by non-management

2 Apr 19

DFAN14A

Additional proxy materials by non-management

26 Mar 19

DEFC14A

Proxy in contested solicitation

22 Mar 19

DFAN14A

Additional proxy materials by non-management

20 Mar 19

SC 13G/A

F-star Therapeutics, Inc.

8 Feb 22

4

Xilio Therapeutics, Inc.

26 Oct 21

3

Xilio Therapeutics, Inc.

21 Oct 21

3

Vera Therapeutics, Inc.

14 May 21

SC 13G/A

Progyny, Inc.

16 Feb 21

SC 13G/A

Progyny, Inc.

4 Feb 21

SC 13G

F-star Therapeutics, Inc.

1 Feb 21

SC 13G

Progyny, Inc.

11 Feb 20

SC 13D/A

INTERMOLECULAR INC

14 Aug 19

SC 13D

INTERMOLECULAR INC

16 May 19